U.S. now requires pharmacogenomics data be included on drug labels. Other countries expected to do the same. The new drug info speeds personalized treatments to patients with preemptive pharmacogenomics tests in their EMRs.
Using the newly created bioinformatics tool, MHcut, with commercial genome-editing technology, enables researchers to model diseases without the need of patient samples. This combination will make it much easier to study diseases even when patients are rare or unavailable.
"If you do experiments, it could take 20 or 30 years to figure it out. With this software system, you can do it in five minutes.”
AI maps and analyzes cellular response to disease and treatments in computational models that go far beyond experimentally available data.
There are some questions too big for even AI on conventional computers to answer within the lifetime of the universe.
Bioinformatics is the key to unlocking the mysteries of nature, finding life-saving cures, and bringing a new age to medicine beyond anything previously imagined.